Therapy gets digital: study tests if reading your texts boosts mental health
NCT ID NCT03712267
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether therapists looking at patients' electronic messages (like texts and emails) during sessions could improve care. About 110 adults with anxiety or depression took part. The goal was to see if this approach helps patients feel better and strengthens their bond with the therapist.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
110 people
The number who actually took part.
- Started
-
Dec 2018
- Finished
-
Aug 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
14 to 85 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Are currently receiving psychotherapy at McLean and have had at least 4 visits with their current therapy provider in outpatient clinics or 2 sessions with their therapy provider in partial hospitalization or residential settings 2. Age 18-85, and fluent in English 3. Have a primary diagnosis of anxiety or depression (as determined by self-report and review of medical records, which should list a primary depression or anxiety spectrum diagnosis). Symptomatology can be active or in remission. 4. Are actively using at least 1 platform for text messaging (i.e. they should have an account on each platform and have produced content within the month prior to beginning the study). This will be based on self report. 5. Use a mobile device for text messaging 6. Able to provide informed consent. Exclusion Criteria: 1. Probable or diagnosed dementia or cognitive impairment, or neurodevelopmental disorder (such as an autism spectrum disorder) based on self report and review of medical records. \- Individuals with Attention-Deficit/Hyperactivity Disorder (ADHD) or Attention-Deficit Disorder (ADD) may be eligible provided symptoms have been stable for at least 6 months. 2. Active psychotic symptoms \- History of psychosis is allowable only if the patient has not had symptoms for at least a year 3. Are actively receiving ECT treatment 4. Current alcohol or drug abuse problem (based on self report and review of medical records) \- History of substance use is fine, provided there has been no relapse or withdrawal symptoms in the month leading up to enrollment 5. Are involuntarily admitted to McLean Hospital
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety disorders are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
McLean Hospital
Belmont, Massachusetts, 02478, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a Text-Message program help trauma survivors avoid PTSD and depression?
- Can a website help young people understand depression?
- Can a brain scan and your phone predict where depression goes next?
- Can a tailored therapy ease anxiety and depression in autistic teens?
- Reading the Brain's signals to predict who benefits from deep brain stimulation